Precision Optics Corporation, Inc. (POCI) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $50.67M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Joseph N. Forkey |
| IPO Date | 1992-01-16 | CAGR | 4.41% |
| Employees | 90 | Website | www.poci.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $36.07M | P/E | -7.35 | Forward P/E | -66.14 | PEG | — |
| P/S | 0.02 | P/B | 0.02 | P/CF | -0.02 | P/FCF | -0.02 |
| Sales | $28.94M | Sales 1Y | 64.18% | Sales 3Y | 39.04% | Sales 5Y | 182.64% |
| EPS | $-0.63 | EPS 1Y | — | EPS 3Y | — | EPS 5Y | — |
| Sales QoQ | 18.2% | EPS QoQ | -93.96% | Sales QoQ Avg | 21.06% | EPS QoQ Avg | -27.64% |
| Gross Margin | 13.85% | Operating Margin | -16.44% | Profit Margin | -17.03% | ROCE | -20.25% |
| ROA | -15% | ROE | -37% | Altman Z Score | 0.43 | Piotroski Score | 5 |
| Current Ratio | 2.1 | Quick Ratio | 1.74 | Cash Ratio | 1.05 | Op. CF Ratio | -0.07 |
| Debt/Equity | 0.21 | Debt/Assets | 0.13 | Lt Debt/Equity | 0.17 | Lt Debt/Cap. | 0.04 |
| Intrst Cov. | -29.75 | Inventory Turnover | 6.73 | Asset Turnover | 0.86 | Receivables Turnover | 4.4 |
| Enterprise Value | $36.07M | P/E Ratio | -7.35 |
| Forward P/E | -66.14 | PEG Ratio | — |
| P/S Ratio | 0.02 | P/B Ratio | 0.02 |
| P/CF Ratio | -0.02 | P/FCF Ratio | -0.02 |
| EPS | $-0.63 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 64.18% | Gross Margin | 13.85% |
| Operating Margin | -16.44% | Profit Margin | -17.03% |
| ROE | -37% | ROA | -15% |
| ROCE | -20.25% | Current Ratio | 2.1 |
| Quick Ratio | 1.74 | Cash Ratio | 1.05 |
| Debt/Equity | 0.21 | Interest Coverage | -29.75 |
| Altman Z Score | 0.43 | Piotroski Score | 5 |
Precision Optics Corporation, Inc. (POCI) valuation & financials
Precision Optics Corporation, Inc. (POCI) has a market capitalization of $50.67M and trades at a price-to-earnings ratio of -7.3. It operates in the Healthcare sector (Medical - Instruments & Supplies).
Precision Optics Corporation, Inc.'s revenue grew +64.2% over the last year.
Precision Optics Corporation, Inc.'s next earnings report is scheduled for September 28, 2026 after market close (provider scheduled date); analysts estimate EPS of $-0.06. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)
Precision Optics Corporation, Inc. revenue & earnings charts →